跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL IRINOTECAN INJECTION CONCENTRATE 20MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
DBL IRINOTECAN INJECTION CONCENTRATE 20MG/ML
Approved
THERAPEUTIC
DBL IRINOTECAN INJECTION CONCENTRATE 20MG/ML
ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Oct 26, 2007
Approval ID
def07e114234d1db
Company
ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
def07e114234d1db
Drug Name
DBL IRINOTECAN INJECTION CONCENTRATE 20MG/ML
Product Name
DBL IRINOTECAN INJECTION CONCENTRATE 20MG/ML
Approval Number
SIN13367P
Approval Date
2007-10-26
Registrant
PFIZER PRIVATE LIMITED
Licence Holder
PFIZER PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01XX19
Atc Item Name
xl 01 xx 19
Pharma Manufacturer Name
PFIZER PRIVATE LIMITED
Active Ingredients
Irinotecan hydrochloride trihydrate
20mg/mL
IRINOTECAN HYDROCHLORIDE TRIHYDRATE
20 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 26, 2007
Approval ID
def07e114234d1db
Type
Therapeutic
Back to HSA Approvals
